Equities researchers at Robert W. Baird assumed coverage on shares of Privia Health Group (NASDAQ:PRVA – Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $23.00 price target on the stock. Robert W. Baird’s target price would suggest a […]
Baird R W upgraded shares of Privia Health Group (NASDAQ:PRVA – Free Report) to a strong-buy rating in a report issued on Thursday morning, Zacks.com reports. A number of other research firms have also recently commented on PRVA. Canaccord Genuity Group lowered their target price on shares of Privia Health Group from $37.00 to $26.00 […]
Privia Health Group (NASDAQ:PRVA – Free Report) had its target price decreased by Barclays from $22.00 to $19.00 in a research report sent to investors on Monday morning, Benzinga reports. Barclays currently has an equal weight rating on the stock. PRVA has been the subject of a number of other reports. Bank of America cut […]
Privia Health Group (NASDAQ:PRVA – Free Report) had its target price trimmed by Truist Financial from $28.00 to $24.00 in a report published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. A number of other research firms also recently weighed in on PRVA. TD Cowen cut their price target on […]
Privia Health Group, Inc. (NASDAQ:PRVA) Receives $27.62 Consensus Target Price from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.